Table 1.

Baseline characteristics

		N	%
Age	≥ 5 years old	15	45.5
	< 5 years old	18	54.5
Menopausal status
	Pre-menopausal	7	21.2
	Post-menopausal	26	78.8
ER/PR status
	positive	17	51.5
	negative	14	42.4
	unknown	2	6.1
HER-2 status
	positive	10	30.3
	negative	13	39.4
	unknown	10	30.3
Metastastic sites
	Viseral metastasis	26	78.8
	Liver	19	57.6
	Lung	15	45.5
	Soft tissue or bone	7	21.2
Previous treatment
	Anthracyclin and Taxane	33	100
	platinum	13	39.4
	5-FU	6	18.2